Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Puig

Showing results (341-350 of 423) with videos related to

Pageof 43
Sort By:
The British Journal of Dermatology|May 19, 2019
Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE studyK Reich, L Puig, J C Szepietowski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisR Strohal, B Kirby, L Puig, et al.
Journal of Viral Hepatitis|March 13, 2012
Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infectionM Bes, S Sauleda, N Casamitjana, et al.
Transfusion|September 1, 1981
Comparative morphology of granulocytes collected by three methods of leukapheresis. A light microscopy and transmission electron microscopy studyE Feliu, S Woessner, E Matutes, et al.
Actas Dermo-Sifiliograficas|April 27, 2019
Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis SuppurativaS E Marrón, M Gómez-Barrera, L Tomás-Aragonés, et al.
Actas Dermo-Sifiliograficas|February 12, 2011
[Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: a consensus statement of the Spanish Psoriasis Group]J M Carrascosa, J L López-Estebaranz, G Carretero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 6, 2020
Definition of minimal disease activity in psoriasisG Carretero, J M Carrascosa, L Puig, et al.
The British Journal of Dermatology|January 23, 2018
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysisD E Stull, C E M Griffiths, I Gilloteau, et al.
Actas Dermo-Sifiliograficas|February 28, 2012
[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]E Daudén, S Castañeda, C Suárez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 27, 2013
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasisU Mrowietz, E M G J de Jong, K Kragballe, et al.
Pageof 43

Showing results (341-350 of 423) with videos related to

Sort By:
Pageof 43
The British Journal of Dermatology|May 19, 2019
Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE studyK Reich, L Puig, J C Szepietowski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisR Strohal, B Kirby, L Puig, et al.
Journal of Viral Hepatitis|March 13, 2012
Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infectionM Bes, S Sauleda, N Casamitjana, et al.
Transfusion|September 1, 1981
Comparative morphology of granulocytes collected by three methods of leukapheresis. A light microscopy and transmission electron microscopy studyE Feliu, S Woessner, E Matutes, et al.
Actas Dermo-Sifiliograficas|April 27, 2019
Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis SuppurativaS E Marrón, M Gómez-Barrera, L Tomás-Aragonés, et al.
Actas Dermo-Sifiliograficas|February 12, 2011
[Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: a consensus statement of the Spanish Psoriasis Group]J M Carrascosa, J L López-Estebaranz, G Carretero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 6, 2020
Definition of minimal disease activity in psoriasisG Carretero, J M Carrascosa, L Puig, et al.
The British Journal of Dermatology|January 23, 2018
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysisD E Stull, C E M Griffiths, I Gilloteau, et al.
Actas Dermo-Sifiliograficas|February 28, 2012
[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]E Daudén, S Castañeda, C Suárez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 27, 2013
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasisU Mrowietz, E M G J de Jong, K Kragballe, et al.
Pageof 43